EIF3A and hepatocellular carcinoma: We detected autoantibody biomarker in human sera using specific conformational cyclic peptide epitope against anti-EIF3A monoclonal autoantibody obtained from HCC model mouse, and also performed multiplex biomarker assay consists of anti-EIF3A autoantibody and other two HCC biomarkers, which enhanced the accuracy of HCC diagnosis.